Package {pharmaverseadamjnj}


Title: J&J Innovative Medicine ADaM Test Data
Version: 0.0.4
Description: A set of Analysis Data Model (ADaM) datasets constructed by modifying the ADaM datasets in the 'pharmaverseadam' package to meet J&J Innovative Medicine's standard data structure for Clinical and Statistical Programming.
License: Apache License (≥ 2)
Encoding: UTF-8
LazyData: true
LazyDataCompression: xz
RoxygenNote: 7.3.3
Language: en-US
Depends: R (≥ 3.5), pharmaverseadam (≥ 1.3.0)
NeedsCompilation: no
Packaged: 2026-05-07 14:48:06 UTC; DTord
Author: David Munoz Tord [aut, cre], Nicholas Masel [aut], Joe Kovach [aut], Mahesh Divakaran [ctb], J&J Innovative Medicine [cph, fnd]
Maintainer: David Munoz Tord <david.munoztord@mailbox.org>
Repository: CRAN
Date/Publication: 2026-05-07 16:41:13 UTC

pharmaverseadamjnj: J&J Innovative Medicine ADaM Test Data

Description

A set of Analysis Data Model (ADaM) datasets constructed by modifying the ADaM datasets in the 'pharmaverseadam' package to meet J&J Innovative Medicine's standard data structure for Clinical and Statistical Programming.

Author(s)

Maintainer: David Munoz Tord david.munoztord@mailbox.org

Authors:

Other contributors:


adae

Description

adae modified from pharmaverseadam

Usage

adae

Format

A data frame with 1191 rows and 83 variables:

USUBJID

Unique Subject Identifier

DOMAIN

Domain Abbreviation

AESEQ

Sequence Number

AETERM

Reported Term for the Adverse Event

AEDECOD

Dictionary-Derived Term

AEBODSYS

Body System or Organ Class

AEBDSYCD

Body System or Organ Class Code

AELLT

Lowest Level Term

AELLTCD

Lowest Level Term Code

AEPTCD

Preferred Term Code

AEHLT

High Level Term

AEHLTCD

High Level Term Code

AEHLGT

High Level Group Term

AEHLGTCD

High Level Group Term Code

AESOC

Primary System Organ Class

AESOCCD

Primary System Organ Class Code

AESTDTC

Start Date/Time of Adverse Event

ASTDT

Analysis Start Date

ASTDTM

Analysis Start Date/Time

ASTDTF

Analysis Start Date Imputation Flag

ASTTMF

Analysis Start Time Imputation Flag

AEENDTC

End Date/Time of Adverse Event

AENDT

Analysis End Date

AENDTM

Analysis End Date/Time

AENDTF

Analysis End Date Imputation Flag

AENTMF

Analysis End Time Imputation Flag

ASTDY

Analysis Start Relative Day

AESTDY

Study Day of Start of Adverse Event

AENDY

Analysis End Relative Day

AEENDY

Study Day of End of Adverse Event

ADURN

Analysis Duration (N)

ADURU

Analysis Duration Units

TRTEMFL

Treatment Emergent Analysis Flag

AOCCIFL

1st Max Sev./Int. Occurrence Flag

AESER

Serious Event

AESDTH

Results in Death

AESLIFE

Is Life Threatening

AESHOSP

Requires or Prolongs Hospitalization

AESDISAB

Persist or Signif Disability/Incapacity

AESCONG

Congenital Anomaly or Birth Defect

AESEV

Severity/Intensity

ASEV

Analysis Severity/Intensity

ASEVN

Analysis Severity/Intensity (N)

AEREL

Causality

AREL

Analysis Causality

AEACN

Action Taken with Study Treatment

AESPID

Sponsor-Defined Identifier

AEOUT

Outcome of Adverse Event

AESCAN

Involves Cancer

AESOD

Occurred with Overdose

AEDTC

Date/Time of Collection

LDOSEDTM

End Date/Time of Last Dose

DOSEON

Treatment Dose at Record Start

DOSEU

Treatment Dose Units

AETOXGR

Standard Toxicity Grade

AETOXGRN

Standard Toxicity Grade (N)

DOSEDY

Day of Study Drug

AECONTRT

Concomitant or Additional Trtmnt Given

CQ01NAM

Customized Query 01 Name

CQ02NAM

Customized Query 02 Name

CQ03NAM

Customized Query 03 Name

AESMIE

Other Medically Important Serious Event

ACAT1

Analysis Category 1

AOCCFL

1st Occurrence within Subject Flag

AOCCPFL

1st Occurrence within Pref Term Flag

AOCCSFL

1st Occurrence of SOC Flag

AOCTIFL

1st TE Max Toxicity Grade Flag

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

AGE

Age

SEX

Sex

RACE

Race

STUDYID

Study Identifier

AGEGR1

Pooled Age Group 1

TRTEDY

Treatment Relative End Day

TRT01P

Planned Treatment for Period 01

TRDISCFL

Treatment Discontinued Flag

AESHOSPP

Prolongs Hospitalization

AESHOSPR

Requires Hospitalization

AESCAT

AESCAT

SMQ01NAM

Standardized MedDRA Query 01 Name

SMQ02NAM

Standardized MedDRA Query 02 Name

SMQ03NAM

Standardized MedDRA Query 03 Name

Source

data from pharmaverseadam.

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("adae"))

adaeocmq

Description

adae modified from pharmaverseadam to include Office of New Drugs (OND) Custom Medical Queries

Usage

adaeocmq

Format

A data frame with 1972 rows and 88 variables:

USUBJID

Unique Subject Identifier

DOMAIN

Domain Abbreviation

AESEQ

Sequence Number

AETERM

Reported Term for the Adverse Event

AEDECOD

AEDECOD

AEBODSYS

Body System or Organ Class

AEBDSYCD

Body System or Organ Class Code

AELLT

Lowest Level Term

AELLTCD

Lowest Level Term Code

AEPTCD

Preferred Term Code

AEHLT

High Level Term

AEHLTCD

High Level Term Code

AEHLGT

High Level Group Term

AEHLGTCD

High Level Group Term Code

AESOC

Primary System Organ Class

AESOCCD

Primary System Organ Class Code

AESTDTC

Start Date/Time of Adverse Event

ASTDT

Analysis Start Date

ASTDTM

Analysis Start Date/Time

ASTDTF

Analysis Start Date Imputation Flag

ASTTMF

Analysis Start Time Imputation Flag

AEENDTC

End Date/Time of Adverse Event

AENDT

Analysis End Date

AENDTM

Analysis End Date/Time

AENDTF

Analysis End Date Imputation Flag

AENTMF

Analysis End Time Imputation Flag

ASTDY

Analysis Start Relative Day

AESTDY

Study Day of Start of Adverse Event

AENDY

Analysis End Relative Day

AEENDY

Study Day of End of Adverse Event

ADURN

Analysis Duration (N)

ADURU

Analysis Duration Units

TRTEMFL

Treatment Emergent Analysis Flag

AOCCIFL

1st Max Sev./Int. Occurrence Flag

AESER

Serious Event

AESDTH

Results in Death

AESLIFE

Is Life Threatening

AESHOSP

Requires or Prolongs Hospitalization

AESDISAB

Persist or Signif Disability/Incapacity

AESCONG

Congenital Anomaly or Birth Defect

AESEV

Severity/Intensity

ASEV

Analysis Severity/Intensity

ASEVN

Analysis Severity/Intensity (N)

AEREL

Causality

AREL

Analysis Causality

AEACN

Action Taken with Study Treatment

AESPID

Sponsor-Defined Identifier

AEOUT

Outcome of Adverse Event

AESCAN

Involves Cancer

AESOD

Occurred with Overdose

AEDTC

Date/Time of Collection

LDOSEDTM

End Date/Time of Last Dose

DOSEON

Treatment Dose at Record Start

DOSEU

Treatment Dose Units

AETOXGR

Standard Toxicity Grade

AETOXGRN

Standard Toxicity Grade (N)

DOSEDY

Day of Study Drug

AECONTRT

Concomitant or Additional Trtmnt Given

CQ01NAM

Customized Query 01 Name

CQ02NAM

Customized Query 02 Name

CQ03NAM

Customized Query 03 Name

AESMIE

Other Medically Important Serious Event

ACAT1

Analysis Category 1

AOCCFL

1st Occurrence within Subject Flag

AOCCPFL

1st Occurrence within Pref Term Flag

AOCCSFL

1st Occurrence of SOC Flag

AOCTIFL

1st TE Max Toxicity Grade Flag

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

AGE

Age

SEX

Sex

RACE

Race

STUDYID

Study Identifier

AGEGR1

Pooled Age Group 1

TRTEDY

Treatment Relative End Day

TRT01P

Planned Treatment for Period 01

TRDISCFL

Treatment Discontinued Flag

AESHOSPP

Prolongs Hospitalization

AESHOSPR

Requires Hospitalization

AESCAT

AESCAT

SMQ01NAM

Standardized MedDRA Query 01 Name

SMQ02NAM

Standardized MedDRA Query 02 Name

SMQ03NAM

Standardized MedDRA Query 03 Name

OCMQNAM

Custom Medical Query Name

OCMQSOC

Custom Medical Query System Organ Class

OCMQCLSS

Custom Medical Query Scope

GENSPMFL

Gender Specific OCMQ Male Flag

GENSPFFL

Gender Specific OCMQ Female Flag

Source

data from adae from pharmaverseadam and, FDA_OCMQ_Consolidated_List.rds and FDA_OCMQ_References.rds

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("adaeocmq"))

adagocmq

Description

adagocmq modified from pharmaverseadam

Usage

adagocmq

Format

A data frame with 1301 rows and 27 variables:

STUDYID

Study Identifier

USUBJID

Unique Subject Identifier

ASTDT

Analysis Start Date

ASTDY

Analysis Start Relative Day

TRT01P

Planned Treatment for Period 01

TRT01PN

Planned Treatment for Period 01 (N)

TRT01A

Actual Treatment for Period 01

TRT01AN

Actual Treatment for Period 01 (N)

ACAT1

Analysis Category 1

ACAT1N

Analysis Category 1 (N)

ATERM

Analysis Term (N)

ATERMN

Analysis Term

HYPSCAT

Hypersensitivity Category

SRCVALUE

Source Value

SRCVAR

Source Variable

SRCDOM

Source Data

SRCSEQ

Source Sequence Number

ANL01FL

Analysis Flag 01

AGE

Age

AGEU

Age Units

SEX

Sex

RACE

Race

COUNTRY

Country

RANDFL

Randomized Flag

SAFFL

Safety Population Flag

SITEID

Study Site Identifier

SUBJID

Subject Identifier for the Study

Source

data from pharmaverseadam.

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("adagocmq"))

adcm

Description

adcm modified from pharmaverseadam

Usage

adcm

Format

A data frame with 7276 rows and 63 variables:

USUBJID

Unique Subject Identifier

DOMAIN

Domain Abbreviation

TRTP

Planned Treatment

TRTA

Actual Treatment

APHASE

Phase

APHASEN

Description of Phase N

CMSEQ

Sequence Number

CMDECOD

Standardized Medication Name

CMTRT

Reported Name of Drug, Med, or Therapy

CMCLAS

Medication Class

CMSTDTC

Start Date/Time of Medication

ASTDT

Analysis Start Date

ASTDTM

Analysis Start Date/Time

ASTDTF

Analysis Start Date Imputation Flag

ASTTMF

Analysis Start Time Imputation Flag

CMENDTC

End Date/Time of Medication

AENDT

Analysis End Date

AENDTM

Analysis End Date/Time

AENDTF

Analysis End Date Imputation Flag

AENTMF

Analysis End Time Imputation Flag

ASTDY

Analysis Start Relative Day

CMSTDY

Study Day of Start of Medication

AENDY

Analysis End Relative Day

CMENDY

Study Day of End of Medication

ADURN

Analysis Duration (N)

ADURU

Analysis Duration Units

ANL01FL

Analysis Flag 01

ONTRTFL

On Treatment Record Flag

PREFL

Pre-treatment Flag

FUPFL

Follow-up Flag

AOCCPFL

1st Occurrence of Preferred Term Flag

CMINDC

Indication

CMDOSE

Dose per Administration

CMDOSU

Dose Units

CMDOSFRQ

Dosing Frequency per Interval

CMROUTE

Route of Administration

CMSPID

Sponsor-Defined Identifier

CMENRTPT

End Relative to Reference Time Point

VISITNUM

Visit Number

VISIT

Visit Name

VISITDY

Planned Study Day of Visit

CMDTC

Date/Time of Collection

CMLVL1

Preferred ATC Text for ATC Level 1

CMLVL2

Preferred ATC Text for ATC Level 2

CMLVL3

Preferred ATC Text for ATC Level 3

CMLVL4

Preferred ATC Text for ATC Level 4

CMBASPRF

Base Preferred Term

CMPRESP

CM Pre-specified

CMOCCUR

CM Occurrence

CMINDCSP

Indication Specification

CMDOSTXT

Dose Description

CMENRF

End Relative to Reference Period

CQ01NAM

Customized Query 01 Name

CQ02NAM

Customized Query 02 Name

CQ03NAM

Customized Query 03 Name

CQ04NAM

Customized Query 04 Name

CQ05NAM

Customized Query 05 Name

CQ06NAM

Customized Query 06 Name

CQ07NAM

Customized Query 07 Name

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

TRTSDT

Date of First Exposure to Treatment

STUDYID

Study Identifier

Source

data from pharmaverseadam.

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("adcm"))

addili

Description

addili modified from pharmaverseadam

Usage

addili

Format

A data frame with 10476 rows and 71 variables:

STUDYID

Study Identifier

USUBJID

Unique Subject Identifier

PARAMCD

Parameter Code

PARAM

Parameter

ADT

Analysis Date

ADTM

Analysis Date/Time

ADY

Analysis Relative Day

AVISIT

Analysis Visit

AVISITN

Analysis Visit (N)

ATPT

Analysis Timepoint

TRTP

Planned Treatment

TRTA

Actual Treatment

AVAL

Analysis Value

BASE

Baseline Value

ANRIND

Analysis Reference Range Indicator

BNRIND

Baseline Reference Range Indicator

ANRLO

Analysis Normal Range Lower Limit

ANRHI

Analysis Normal Range Upper Limit

ABLFL

Baseline Record Flag

APOBLFL

Post-Baseline Record Flag

ONTRTFL

On Treatment Record Flag

LBSEQ

Sequence Number

VISIT

Visit Name

VISITNUM

Visit Number

LBNAM

Laboratory Name

DTYPE

Derivation Type

TRT01P

Planned Treatment for Period 01

TRT01PN

Planned Treatment for Period 01 (N)

TRT01A

Actual Treatment for Period 01

TRT01AN

Actual Treatment for Period 01 (N)

TRTSDT

Date of First Exposure to Treatment

TRTSDTM

Datetime of First Exposure to Treatment

TRTEDT

Date of Last Exposure to Treatment

TRTEDTM

Datetime of Last Exposure to Treatment

AGE

Age

AGEU

Age Units

AGEGR1

Pooled Age Group 1

AGEGR1N

Pooled Age Group 1 (N)

SEX

Sex

RACE

Race

COUNTRY

Country

SAFFL

Safety Population Flag

FASFL

Full Analysis Set Population Flag

RANDFL

Randomized Population Flag

DTHFL

Subject Death Flag

SITEID

Study Site Identifier

SUBJID

Subject Identifier for the Study

PARCAT1

Parameter Category 1

R2ANRHI

Ratio to ANR Upper Limit

CRIT1

Analysis Criterion 1

CRIT1FL

Criterion 1 Evaluation Result Flag

CRIT2

Analysis Criterion 2

CRIT2FL

Criterion 2 Evaluation Result Flag

CRIT3

Analysis Criterion 3

CRIT3FL

Criterion 3 Evaluation Result Flag

CRIT4

Analysis Criterion 4

CRIT4FL

Criterion 4 Evaluation Result Flag

CRIT5

Analysis Criterion 5

CRIT5FL

Criterion 5 Evaluation Result Flag

ANL04FL

Analysis 04 Record Flag

ANL06FL

Analysis 06 Record Flag

ANL05FL

Analysis 05 Record Flag

ANL07FL

Analysis 07 Record Flag

ANL02FL

Analysis 02 Record Flag

ANL03FL

Analysis 03 Record Flag

AVALC

Analysis Value (C)

AVALCAT1

Analysis Value Category 1

AVALCA1N

Analysis Value Category 1 (N)

AVALCAT2

Analysis Value Category 2

AVALCA2N

Analysis Value Category 2 (N)

ASEQ

Analysis Sequence Number

Source

data from pharmaverseadam.

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("addili"))

adeg

Description

adeg modified from pharmaverseadam

Usage

adeg

Format

A data frame with 13536 rows and 70 variables:

USUBJID

Unique Subject Identifier

DOMAIN

Domain Abbreviation

ASEQ

Analysis Sequence Number

TRTP

Planned Treatment

TRTA

Actual Treatment

ADT

Analysis Date

ADTM

Analysis Datetime

ADY

Analysis Relative Day

ATMF

Analysis Time Imputation Flag

AVISIT

Analysis Visit

AVISITN

Analysis Visit (N)

ATPT

Analysis Timepoint

ATPTN

Analysis Timepoint (N)

PARAM

Parameter

PARAMCD

Parameter Code

PARAMN

Parameter (N)

AVAL

Analysis Value

AVALC

Analysis Value (C)

AVALCAT1

Analysis Value Category 1

AVALCA1N

Analysis Value Category 1 (N)

BASEC

Baseline Value (C)

BASETYPE

Baseline Type

CHG

Change from Baseline

CHGCAT1

Change from Baseline Category 1

CHGCAT1N

Change from Baseline Category 1 (N)

PCHG

Percent Change from Baseline

DTYPE

Derivation Type

ANRIND

Analysis Reference Range Indicator

ANRLO

Analysis Normal Range Lower Limit

ANRHI

Analysis Normal Range Upper Limit

ABLFL

Baseline Record Flag

ANL01FL

Analysis Flag 01-Analysis Value

ONTRTFL

On Treatment Record Flag

EGSEQ

Sequence Number

EGTESTCD

ECG Test or Examination Short Name

EGTEST

ECG Test or Examination Name

EGORRES

Result or Finding in Original Units

EGORRESU

Original Units

EGSTRESC

Character Result/Finding in Std Format

EGSTRESN

Numeric Result/Finding in Standard Units

EGSTRESU

Standard Units

EGSTAT

Completion Status

EGLOC

Lead Location Used for Measurement

EGBLFL

Baseline Flag

VISITNUM

Visit Number

VISIT

Visit Name

VISITDY

Planned Study Day of Visit

EGDTC

Date/Time of ECG

EGDY

Study Day of ECG

EGTPT

Planned Time Point Name

EGTPTNUM

Planned Time Point Number

EGELTM

Planned Elapsed Time from Time Point Ref

EGTPTREF

Time Point Reference

TRTEMFL

Treatment Emergent Analysis Flag

ANL02FL

Analysis Flag 02-By Visit Value

ANL03FL

Analysis Flag 03-Maximum Value

APOBLFL

Post-Baseline Record Flag

CRIT1

Analysis Criterion 1

CRIT1FL

Criterion 1 Evaluation Result Flag

CRIT2

Analysis Criterion 2

CRIT2FL

Criterion 2 Evaluation Result Flag

EGCLSIG

Clinically Significant

BASE

Baseline Value

BNRIND

Baseline Reference Range Indicator

BASECAT1

Baseline Category 1

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

STUDYID

Study Identifier

AGE

Age

SEX

Sex

Source

data from pharmaverseadam.

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("adeg"))

adex

Description

adex modified from pharmaverseadam

Usage

adex

Format

A data frame with 591 rows and 130 variables:

STUDYID

Study Identifier

USUBJID

Unique Subject Identifier

SUBJID

Subject Identifier for the Study

SITEID

Study Site Identifier

COUNTRY

Country

DOMAIN

Domain Abbreviation

RFSTDTC

Subject Reference Start Date/Time

RFENDTC

Subject Reference End Date/Time

RFXSTDTC

Date/Time of First Study Treatment

RFXENDTC

Date/Time of Last Study Treatment

RFPENDTC

Date/Time of End of Participation

SCRFDT

Screen Failure Date

FRVDT

Final Retrieval Visit Date

DTHDTC

Date/Time of Death

DTHADY

Relative Day of Death

DTHFL

Subject Death Flag

LDDTHELD

Elapsed Days from Last Dose to Death

LDDTHGR1

Last Dose to Death - Days Elapsed Grp 1

DTH30FL

Death Within 30 Days of Last Trt Flag

DTHA30FL

Death After 30 Days from Last Trt Flag

DTHDOM

Domain for Date of Death Collection

DTHB30FL

Death Within 30 Days of First Trt Flag

ASEQ

Analysis Sequence Number

REGION1

Geographic Region 1

DMDTC

Date/Time of Collection

DMDY

Study Day of Collection

AGE

Age

AGEU

Age Units

AGEGR1

Age Group

SEX

Sex

RACE

Race

RACEGR1

Pooled Race Group 1

ETHNIC

Ethnicity

SAFFL

Safety Population Flag

ARM

Treatment Group

ARMCD

Treatment Category Code

ACTARM

Actual Treatment Group

ACTARMCD

Actual Arm Code

TRT01P

Planned Treatment for Period 01

TRT01A

Actual Treatment for Period 01

TRTSDT

Date of First Exposure to Treatment

TRTSDTM

Datetime of First Exposure to Treatment

TRTSTMF

Time of First Exposure Imput. Flag

TRTEDT

Date of Last Exposure to Treatment

TRTEDTM

Datetime of Last Exposure to Treatment

TRTETMF

Time of Last Exposure Imput. Flag

EOSSTT

End of Study Status

EOSDT

End of Study Date

RFICDTC

Date/Time of Informed Consent

RANDDT

Date of Randomization

LSTALVDT

Date Last Known Alive

TRTDURD

Total Treatment Duration (Days)

DTHDT

Date of Death

DTHDTF

Date of Death Imputation Flag

DTHCAUS

Cause of Death

DTHCGR1

Cause of Death Reason 1

EXTRT

Planned Treatment

EXDOSE

Adjusted Dose

EXDOSFRM

Dose Form

EXDOSFRQ

Dosing Frequency per Interval

EXROUTE

Route of Administration

EXADJ

Reason for Dose Adjustment

EXSTDTC

Start Date/Time of Treatment

EXENDTC

End Date/Time of Treatment

EXSTDY

Study Day of Start of Treatment

EXENDY

Study Day of End of Treatment

EXSEQ

Sequence Number

ASTDT

Analysis Start Date

AENDT

Analysis End Date

EXDURD

Duration of Treatment (Days)

EXDOSU

Dose Units

VISITNUM

Visit Number

VISIT

Visit Name

VISITDY

Planned Study Day of Visit

EXPLDOS

Planned Dose

ASTDTM

Analysis Start Datetime

ASTDTF

Analysis Start Date Imputation Flag

ASTTMF

Analysis Start Time Imputation Flag

AENDTM

Analysis End Datetime

AENDTF

Analysis End Date Imputation Flag

AENTMF

Analysis End Time Imputation Flag

ASTDY

Analysis Start Relative Day

AENDY

Analysis End Relative Day

DOSEO

Dose O

PDOSEO

PDose O

PARAMCD

Parameter Code

AVAL

Analysis Value

AVALC

Analysis Value (C)

PARCAT1

Parameter Category 1

PARAM

Parameter

PARAMN

Parameter (N)

AVALCAT1

Analysis Value Category 1

ATRT

Analysis name of Treatment

DAEXPDTC

Date of Exposure

EXLOT

Lot Number

ADOSE

Analysis Dose

TRT01PN

Planned Treatment for Period 01 (N)

AVISITN

Visit Number

AVISIT

Visit Label

TRT01AN

Actual Treatment for Period 01 (N)

AOCCUR

Analysis Occurrence

ACAT1

Analysis Category 1

AREASOC

Analysis Reason for Occur Value

AREASOO

Other Analysis Reason for Occur Value

AADJ

Analysis Reason for Dose Adjustment

AADJPOTH

Other Anal Reason for Dose Adjust Prior

AADJP

Analysis Reason for Prior Dose Adjust

AACTDU

Analysis Action Taken During Study Trt

AACTDU1

Act Takn Dur Infus-Full Dose Admined

AACTDU2

Act Takn Dur Infus-Infusion Aborted

AACTDU3

Act Takn Dur Infus-Infusion Interrupted

AACTDU4

Act Takn Dur Infus-Infusion Rate Decrsed

AACTDU5

Act Takn Dur Infus-Infusion Rate Incrsed

AADJOTH

Other Anal Reason for Dose Adjustment

ACAT2

Analysis Category 2

AACTPR

Action Taken Prior to Infusion Start

ASCHDOSE

Analysis Scheduled Dose

ASCHDOSU

Analysis Scheduled Dose Units

ADOSFRM

Analysis Dose Form

ADOSU

Analysis Dose Units

ADOSFRQ

Analysis Dosing Frequency per Interval

AROUTE

Analysis Route of Administration

ATVINF

Analysis Total Volume Infused

ATVINFU

Analysis Total Volume Infused Units

AINFRAT

Analysis Infusion Rate

AINFRAU

Analysis Infusion Rate Unit

ABODSYS1

AE SOC Driving Study Drug Action (1)

ABODSYS2

AE SOC Driving Study Drug Action (2)

ADECOD1

AE PT Driving Study Drug Action (1)

ADECOD2

AE PT Driving Study Drug Action (2)

Source

data from pharmaverseadam.

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("adex"))

adexsum

Description

adex modified from pharmaverseadam

Usage

adexsum

Format

A data frame with 2794 rows and 25 variables:

USUBJID

Unique Subject Identifier

PARAMCD

Parameter Code

PARAM

Parameter

AVAL

Analysis Value

AVALCAT1

Analysis Value Category 1

AVALCA1N

Analysis Value Category 1 (N)

CRIT1

Analysis Criterion 1

CRIT1FL

Criterion 1 Evaluation Result Flag

CRIT2

Analysis Criterion 2

CRIT2FL

Criterion 2 Evaluation Result Flag

CRIT3

Analysis Criterion 3

CRIT3FL

Criterion 3 Evaluation Result Flag

CRIT4

Analysis Criterion 4

CRIT4FL

Criterion 4 Evaluation Result Flag

CRIT5

Analysis Criterion 5

CRIT5FL

Criterion 5 Evaluation Result Flag

CRIT6

Analysis Criterion 6

CRIT6FL

Criterion 6 Evaluation Result Flag

CRIT7

Analysis Criterion 7

CRIT7FL

Criterion 7 Evaluation Result Flag

AVISIT

Analysis Visit

AVISITN

Analysis Visit (N)

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

STUDYID

Study Identifier

Source

data from adex from pharmaverseadam

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("adexsum"))

adlb

Description

adlb modified from pharmaverseadam

Usage

adlb

Format

A data frame with 83640 rows and 153 variables:

STUDYID

Study Identifier

USUBJID

Unique Subject Identifier

SUBJID

Subject Identifier for the Study

SITEID

Study Site Identifier

COUNTRY

Country

DOMAIN

Domain Abbreviation

RFSTDTC

Subject Reference Start Date/Time

RFENDTC

Subject Reference End Date/Time

RFXSTDTC

Date/Time of First Study Treatment

RFXENDTC

Date/Time of Last Study Treatment

RFPENDTC

Date/Time of End of Participation

SCRFDT

Screen Failure Date

FRVDT

Final Retrieval Visit Date

DTHDTC

Date/Time of Death

DTHADY

Relative Day of Death

DTHFL

Subject Death Flag

LDDTHELD

Elapsed Days from Last Dose to Death

LDDTHGR1

Last Dose to Death - Days Elapsed Grp 1

DTH30FL

Death Within 30 Days of Last Trt Flag

DTHA30FL

Death After 30 Days from Last Trt Flag

DTHDOM

Domain for Date of Death Collection

DTHB30FL

Death Within 30 Days of First Trt Flag

ASEQ

Analysis Sequence Number

REGION1

Geographic Region 1

DMDTC

Date/Time of Collection

DMDY

Study Day of Collection

AGE

Age

AGEU

Age Units

SEX

Sex

RACE

Race

RACEGR1

Pooled Race Group 1

ETHNIC

Ethnicity

SAFFL

Safety Population Flag

ARM

Description of Planned Arm

ARMCD

Planned Arm Code

ACTARM

Description of Actual Arm

ACTARMCD

Actual Arm Code

TRTP

Planned Treatment

TRTA

Actual Treatment

TRT01P

Planned Treatment for Period 01

TRT01A

Actual Treatment for Period 01

TRTSDT

Date of First Exposure to Treatment

TRTSDTM

Datetime of First Exposure to Treatment

TRTSTMF

Time of First Exposure Imput. Flag

TRTEDT

Date of Last Exposure to Treatment

TRTEDTM

Datetime of Last Exposure to Treatment

TRTETMF

Time of Last Exposure Imput. Flag

EOSSTT

End of Study Status

EOSDT

End of Study Date

RFICDTC

Date/Time of Informed Consent

RANDDT

Date of Randomization

LSTALVDT

Date Last Known Alive

TRTDURD

Total Treatment Duration (Days)

DTHDT

Date of Death

DTHDTF

Date of Death Imputation Flag

DTHCAUS

Cause of Death

DTHCGR1

Cause of Death Reason 1

ADT

Analysis Date

ADY

Analysis Relative Day

AVISIT

Analysis Visit

AVISITN

Analysis Visit (N)

PARAM

Parameter

PARAMCD

Parameter Code

PARAMN

Parameter (N)

PARCAT1

Parameter Category 1

AVAL

Analysis Value

AVALC

Analysis Value (C)

BASE

Baseline Value

BASEC

Baseline Value (C)

BASETYPE

Baseline Type

CHG

Change from Baseline

PCHG

Percent Change from Baseline

R2BASE

Ratio to Baseline

R2ANRLO

Ratio of Analysis Val compared to ANRLO

R2ANRHI

Ratio of Analysis Val compared to ANRHI

SHIFT1

Shift from Baseline to Analysis Value

SHIFT2

Shift from Baseline to Overall Grade

DTYPE

Derivation Type

ATOXGR

Analysis Toxicity Grade

BTOXGR

Baseline Toxicity Grade

ANRIND

Analysis Reference Range Indicator

BNRIND

Baseline Reference Range Indicator

ANRLO

Analysis Normal Range Lower Limit

ANRHI

Analysis Normal Range Upper Limit

ATOXGRL

Analysis Toxicity Grade Low

ATOXGRH

Analysis Toxicity Grade High

BTOXGRL

Baseline Toxicity Grade Low

BTOXGRH

Baseline Toxicity Grade High

ATOXDSCL

Analysis Toxicity Description Low

ATOXDSCH

Analysis Toxicity Description High

ABLFL

Baseline Record Flag

ANL01FL

Analysis Flag 01

ONTRTFL

On Treatment Record Flag

LVOTFL

Last Value On Treatment Record Flag

LBSEQ

Sequence Number

LBTESTCD

Lab Test or Examination Short Name

LBTEST

Lab Test or Examination Name

LBCAT

Category for Lab Test

LBORRES

Result or Finding in Original Units

LBORRESU

Original Units

LBORNRLO

Reference Range Lower Limit in Orig Unit

LBORNRHI

Reference Range Upper Limit in Orig Unit

LBSTRESC

Character Result/Finding in Std Format

LBSTRESN

Numeric Result/Finding in Standard Units

LBSTRESU

Standard Units

LBSTNRLO

Reference Range Lower Limit-Std Units

LBSTNRHI

Reference Range Upper Limit-Std Units

LBNRIND

Reference Range Indicator

LBBLFL

Baseline Flag

VISITNUM

Visit Number

VISIT

Visit Name

VISITDY

Planned Study Day of Visit

LBDTC

Date/Time of Specimen Collection

LBDY

Study Day of Specimen Collection

TRT01PN

Planned Treatment for Period 01 (N)

TRT01AN

Actual Treatment for Period 01 (N)

AVALU

Analysis Value - Units

ANL02FL

Analysis Record Flag 02-Analysis Value

TRTEMFL

Treatment Emergent Analysis Flag

PARCAT2

Parameter Category 2

PARCAT3

Parameter Category 3

PARCAT4

Parameter Category 4

PARCAT5

Parameter Category 5

PARCAT6

Parameter Category 6

MCRIT2ML

Multi-Response Criterion 2 Evaluation

MCRIT1ML

Multi-Response Criterion 1 Evaluation

MCRIT1MN

Multi-Response Criterion 1 Eval (N)

MCRIT2MN

Multi-Response Criterion 2 Eval (N)

MCRIT1

Analysis Multi-Response Criterion 1

MCRIT2

Analysis Multi-Response Criterion 2

APOBLFL

Post-Baseline Record Flag

LBSTNRHQ

Reference Limit Higher

LBSTNRLQ

Reference Limit Lower

ATOXGRN

Analysis Toxicity Grade (Numeric)

ADTM

Analysis Date/Time

ATPT

Analysis Timepoint

LBCLSIG

Clinically Significant

TR01SDT

Start Date of Treatment for Period 01

TR01EDT

End Date of Treatment for Period 01

LBSPEC

Specimen Type

LBFAST

Fasting Status

LBNAM

Laboratory Name

ANL03FL

Analysis Record Flag 03 - Protocol Visit

ANL04FL

Analysis Flag 04

ANL05FL

Analysis Flag 05

ANL06FL

Analysis Flag 06

ANL07FL

Analysis Flag 07

ANL08FL

Analysis Flag 08

ANL09FL

Analysis Flag 09

ANL10FL

Analysis Flag 10

ANL14FL

Analysis Flag 14

ANL15FL

Analysis Flag 15

ANL16FL

Analysis Flag 16

Source

data from pharmaverseadam.

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("adlb"))

adpc

Description

adpc modified from pharmaverseadam

Usage

adpc

Format

A data frame with 4479 rows and 130 variables:

STUDYID

Study Identifier

USUBJID

Unique Subject Identifier

SUBJID

Subject Identifier for the Study

SITEID

Study Site Identifier

COUNTRY

Country

RFSTDTC

Subject Reference Start Date/Time

RFENDTC

Subject Reference End Date/Time

RFXSTDTC

Date/Time of First Study Treatment

RFXENDTC

Date/Time of Last Study Treatment

RFPENDTC

Date/Time of End of Participation

SCRFDT

Screen Failure Date

FRVDT

Final Retrieval Visit Date

DTHDTC

Date/Time of Death

DTHADY

Relative Day of Death

DTHFL

Subject Death Flag

LDDTHELD

Elapsed Days from Last Dose to Death

LDDTHGR1

Last Dose to Death - Days Elapsed Grp 1

DTH30FL

Under 30 Group

DTHA30FL

Over 30 Group

DTHDOM

Domain for Date of Death Collection

DTHB30FL

Over 30 plus 30 days Group

ASEQ

Analysis Sequence Number

REGION1

Geographic Region 1

DMDTC

Date/Time of Collection

DMDY

Study Day of Collection

AGE

Age

AGEU

Age Units

AGEGR1

Pooled Age Group 1

SEX

Sex

RACE

Race

RACEGR1

Pooled Race Group 1

ETHNIC

Ethnicity

SAFFL

Safety Population Flag

ARM

Description of Planned Arm

ARMCD

Planned Arm Code

ACTARM

Description of Actual Arm

ACTARMCD

Actual Arm Code

TRT01P

Planned Treatment for Period 01

TRT01A

Actual Treatment for Period 01

TRTSDT

Date of First Exposure to Treatment

TRTSDTM

Datetime of First Exposure to Treatment

TRTSTMF

Time of First Exposure Imput. Flag

TRTEDT

Date of Last Exposure to Treatment

TRTEDTM

Datetime of Last Exposure to Treatment

TRTETMF

Time of Last Exposure Imput. Flag

EOSSTT

End of Study Status

EOSDT

End of Study Date

RFICDTC

Date/Time of Informed Consent

RANDDT

Date of Randomization

LSTALVDT

Date Last Known Alive

TRTDURD

Total Treatment Duration (Days)

DTHDT

Date of Death

DTHDTF

Date of Death Imputation Flag

DTHCAUS

Cause of Death

DTHCGR1

Cause of Death Reason 1

DOSEP

Planned Treatment Dose

DOSEA

Actual Treatment Dose

DOSEU

Treatment Dose Units

ADT

Analysis Date

ATM

Analysis Time

ADTM

Analysis Datetime

ADY

Analysis Relative Day

ATMF

Analysis Time Imputation Flag

ASTDT

Analysis Start Date

ASTTM

Analysis Start Time

ASTDTM

Analysis Start Datetime

AENDT

Analysis End Date

AENTM

Analysis End Time

AENDTM

Analysis End Datetime

AVISIT

Analysis Visit

AVISITN

Analysis Visit (N)

ATPT

Analysis Timepoint

ATPTN

Analysis Timepoint (N)

ATPTREF

Analysis Timepoint Reference

PARAM

Parameter

PARAMCD

Parameter Code

PARAMN

Parameter (N)

PARCAT1

Parameter Category 1

AVAL

Analysis Value

AVALU

Analysis Value Unit

AVALCAT1

Analysis Value Category 1

BASE

Baseline Value

BASETYPE

Baseline Type

CHG

Change from Baseline

DTYPE

Derivation Type

ABLFL

Baseline Record Flag

ANL01FL

Analysis Flag 01

ANL02FL

Analysis Flag 02

SRCDOM

Source Data

SRCVAR

Source Variable

SRCSEQ

Source Sequence Number

NFRLT

Nom. Rel. Time from Analyte First Dose

PCTESTCD

Pharmacokinetic Test Short Name

PCTEST

Pharmacokinetic Test Name

PCORRES

Result or Finding in Original Units

PCORRESU

Original Units

PCSTRESC

Character Result/Finding in Std Format

PCSTRESN

Numeric Result/Finding in Standard Units

PCSTRESU

Standard Units

PCNAM

Vendor Name

PCSPEC

Specimen Material Type

PCLLOQ

Lower Limit of Quantitation

VISIT

Visit Name

VISITNUM

Visit Number

VISITDY

Planned Study Day of Visit

PCDTC

Date/Time of Specimen Collection

PCDY

Actual Study Day of Specimen Collection

PCTPT

Planned Time Point Name

PCTPTNUM

Planned Time Point Number

FANLDTM

First Datetime of Dose for Analyte

AFRLT

Act. Rel. Time from Analyte First Dose

ARRLT

Actual Rel. Time from Ref. Dose

PCRFTDTM

Reference Datetime of Dose for Analyte

FANLDT

First Date of Dose for Analyte

FANLTM

First Time of Dose for Analyte

PCRFTDT

Reference Date of Dose for Analyte

PCRFTTM

Reference Time of Dose for Analyte

NRRLT

Nominal Rel. Time from Ref. Dose

FRLTU

Rel. Time from First Dose Unit

RRLTU

Rel. Time from Ref. Dose Unit

ALLOQ

Analysis Lower Limit of Quantitation

MRRLT

Modified Rel. Time from Ref. Dose

HTBL

Numeric Result/Finding in Standard Units

HTBLU

Standard Units

WTBL

Numeric Result/Finding in Standard Units

WTBLU

Standard Units

BMIBL

Baseline Body Mass Index (kg/m2)

BMIBLU

BMI at Baseline (Unit)

CRIT1

Lowest Quantification Level Criterion

CRIT1FL

Lowest Quantification Level Flag

Source

data from pharmaverseadam.

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("adpc"))

adsl

Description

adsl modified from pharmaverseadam

Usage

adsl

Format

A data frame with 306 rows and 116 variables:

STUDYID

Study Identifier

USUBJID

Unique Subject Identifier

SUBJID

Subject Identifier for the Study

SITEID

Study Site Identifier

COUNTRY

Country

RFSTDTC

Subject Reference Start Date/Time

RFENDTC

Subject Reference End Date/Time

RFXSTDTC

Date/Time of First Study Treatment

RFXENDTC

Date/Time of Last Study Treatment

RFPENDTC

Date/Time of End of Participation

SCRFDT

Screen Failure Date

FRVDT

Final Retrieval Visit Date

DTHDTC

Date/Time of Death

DTHADY

Relative Day of Death

DTHFL

Subject Death Flag

LDDTHELD

Elapsed Days from Last Dose to Death

LDDTHGR1

Last Dose to Death - Days Elapsed Grp 1

DTH30FL

Death Within 30 Days of Last Trt Flag

DTHA30FL

Death After 30 Days from Last Trt Flag

DTHDOM

Domain for Date of Death Collection

DTHB30FL

Death Within 30 Days of First Trt Flag

REGION1

Geographic Region 1

DMDTC

Date/Time of Collection

DMDY

Study Day of Collection

AGE

Age

AGEU

Age Units

AGEGR1

Pooled Age Group 1

SEX

Sex

RACE

Race

RACEGR1

Pooled Race Group 1

ETHNIC

Ethnicity

SAFFL

Safety Population Flag

ARM

Description of Planned Arm

ARMCD

Planned Arm Code

ACTARM

Description of Actual Arm

ACTARMCD

Actual Arm Code

TRT01P

Planned Treatment for Period 01

TRT01A

Actual Treatment for Period 01

TRTSDT

Date of First Exposure to Treatment

TRTSDTM

Datetime of First Exposure to Treatment

TRTSTMF

Time of First Exposure Imput. Flag

TRTEDT

Date of Last Exposure to Treatment

TRTEDTM

Datetime of Last Exposure to Treatment

TRTETMF

Time of Last Exposure Imput. Flag

EOSSTT

End of Study Status

EOSDT

End of Study Date

RFICDTC

Date/Time of Informed Consent

RANDDT

Date of Randomization

LSTALVDT

Date Last Known Alive

TRTDURD

Total Treatment Duration (Days)

DTHDT

Date of Death

DTHDTF

Date of Death Imputation Flag

DTHCAUS

Cause of Death

DTHCGR1

Cause of Death Reason 1

BRTHDTC

Date/Time of Birth

TRT01PN

Planned Treatment for Period 01 (N)

TRT01AN

Actual Treatment for Period 01 (N)

AGEGR1N

Pooled Age Group 1 (N)

WEIGHTBL

Weight (kg)

WGTGR1N

Weight Group 1 (N)

WGTGR1

Weight Group 1

HEIGHTBL

Height (cm)

BSABL

Body surface area (m2)

BMIBL

Body mass index (kg/m2)

BMIBLG1N

BMI at Baseline Group 1 (N)

BMIBLG1

BMI at Baseline Group 1

RFICDT

Date of Informed Consent

STRAT1D

Description of Stratification Factor 1

STRAT2D

Description of Stratification Factor 2

STRAT1R

Strat Factor 1 Value Used for Rand

STRAT2R

Strat Factor 2 Value Used for Rand

RANUM

Randomization Number

RANDDTM

Datetime of Randomization

EOTSTT

End of Treatment Status

DCTREAS

Reason for Discontinuation of Treatment

LTVISIT

Last Treatment Visit

DCTREASP

Reason Specify for Discont of Treatment

DCTDT

End of Study Date

DCSREAS

Reason for Discontinuation from Study

DCSREASP

Reason Spec for Discont from Study

LSVISIT

Last Study Visit

TRTEDY

Treatment Relative End Day

SCRNFL

Screened Population Flag

SCRFFL

Screen Failure Flag

DCSCREEN

Reason for Discont During Screening

ENRLFL

Enrolled Population Flag

RANDFL

Randomized Flag

ITTFL

Intent-To-Treat Population Flag

FASFL

Full Analysis Set Population Flag

PPROTFL

Per-Protocol Population Flag

LSTSVDT

Last Subject Visit (SV) Date

LASTCTDT

Last Contact Date

EOSDY

Study Day of Study Termination

UNBLNDFL

Subject Blind Broken

RESCRNFL

Re-screened Flag

DTHTRTFL

Death on Treatment Flag

DTHCAUSP

Cause Spec for Death

DTHAFTFL

Death After 30 Days of Last Treatment

DTHB60FL

Death Within 60 Days of First Treatment

UNBLNDDT

Date of Unblinding

UNBLNDDY

Study Day of Unblinding

UNBREAS

Reason For Unblinding

LDOSE

Last Dose

LDOSU

Last Dose Unit

DTHTERM

Reported Cause of Death

LDSTODTH

Days from Last Dose to Death

DTHDY

Study Day of Death

PKFL

Pharmacokinetic Population Flag

DIABETFL

History of Diabetes

IMFL

Immunogenicity Population Flag

DCTADY

Study Day of Treatment Discontinuation

SAFEXRS

Reason for Excl from Safety Population

FASEXRS

Reason for Excl from Full Analysis Set

PPREXRS

Reason for Excl from Per-Prot Population

PKEXRES

Reason for Excl from Pharmacokin Pop

IMEXRES

Reason for Excl from Immunogen Pop

Source

data from pharmaverseadam.

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("adsl"))

adttesaf

Description

adtte_onc modified from pharmaverseadam

Usage

adttesaf

Format

A data frame with 2032 rows and 9 variables:

USUBJID

Unique Subject Identifier

PARAMCD

Parameter Code

PARAM

Parameter

AVAL

Analysis Value

CNSR

Censor

STARTDT

Start Date

ADT

Analysis Date

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

Source

data from adtte_onc from pharmaverseadam

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("adttesaf"))

advs

Description

advs modified from pharmaverseadam

Usage

advs

Format

A data frame with 50080 rows and 90 variables:

USUBJID

Unique Subject Identifier

DOMAIN

Domain Abbreviation

ASEQ

Analysis Sequence Number

TRTP

Planned Treatment

TRTA

Actual Treatment

ADT

Analysis Date

ADY

Analysis Relative Day

AVISIT

Analysis Visit

AVISITN

Analysis Visit (N)

ATPT

Analysis Time Point

ATPTN

Analysis Timepoint (N)

PARAM

Parameter

PARAMCD

Parameter Code

PARAMN

Parameter (N)

AVAL

Analysis Value

AVALCAT1

Analysis Value Category 1

AVALCA1N

Analysis Value Category 1 (N)

BASETYPE

Baseline Type

CHG

Change from Baseline

PCHG

Percent Change from Baseline

DTYPE

Derivation Type

ANRIND

Analysis Reference Range Indicator

ANRLO

Analysis Normal Range Lower Limit

ANRHI

Analysis Normal Range Upper Limit

A1LO

Analysis Range 1 Lower Limit

A1HI

Analysis Range 1 Upper Limit

ABLFL

Baseline Record Flag

ANL01FL

Analysis Flag 01

ONTRTFL

On Treatment Record Flag

VSSEQ

Sequence Number

VSTESTCD

Vital Signs Test Short Name

VSTEST

Vital Signs Test Name

VSPOS

Vital Signs Position of Subject

VSORRES

Result or Finding in Original Units

VSORRESU

Original Units

VSSTRESC

Character Result/Finding in Std Format

VSSTRESN

Numeric Result/Finding in Standard Units

VSSTRESU

Standard Units

VSSTAT

Completion Status

VSLOC

Location of Vital Signs Measurement

VSBLFL

Baseline Flag

VISITNUM

Visit Number

VISIT

Visit Name

VISITDY

Planned Study Day of Visit

VSDTC

Date/Time of Measurements

VSDY

Study Day of Vital Signs

VSTPT

Planned Time Point Name

VSTPTNUM

Planned Time Point Number

VSELTM

Planned Elapsed Time from Time Point Ref

VSTPTREF

Time Point Reference

AVALC

Analysis Value (C)

ASTDT

ASTDT

ANL02FL

Analysis Flag 02-By Visit Value

APOBLFL

Post-Baseline Record Flag

BASE

Baseline Value

BNRIND

Baseline Reference Range Indicator

ADTM

Analysis Date/Time

CRIT1

Analysis Criterion 1

CRIT1FL

Criterion 1 Evaluation Result Flag

CRIT2

Analysis Criterion 2

CRIT2FL

Criterion 2 Evaluation Result Flag

CRIT3

Analysis Criterion 3

CRIT3FL

Criterion 3 Evaluation Result Flag

CRIT4

CRIT4

CRIT4FL

CRIT4FL

CRIT5

CRIT5

CRIT5FL

CRIT5FL

CRIT6

CRIT6

CRIT6FL

CRIT6FL

CRIT7

CRIT7

CRIT7FL

CRIT7FL

CRIT8

CRIT8

CRIT8FL

CRIT8FL

VSCLSIG

VSCLSIG

ATOXDSCL

Analysis Toxicity Description Low

ATOXDSCH

Analysis Toxicity Description High

ATOXGRL

Analysis Toxicity Grade Low

ATOXGRH

Analysis Toxicity Grade High

ATOXGR

Analysis Toxicity Grade

ANL06FL

Analysis Flag 06-Minimum Value

ANL05FL

Analysis Flag 05-Worst Tox Grade High

ANL04FL

Analysis Flag 04-Worst Value

ANL03FL

Analysis Flag 03-Maximum Value

TRTEMFL

Treatment Emergent Analysis Flag

TRT01A

Actual Treatment for Period 01

SAFFL

Safety Population Flag

STUDYID

Study Identifier

AGE

Age

SEX

Sex

RACE

Race

Source

data from pharmaverseadam.

See Also

adae adaeocmq adagocmq adcm addili adeg adex adexsum adlb adpc adsl adttesaf advs# nolint

Examples

head(data("advs"))